What to expect from the #SIU2025Edinburgh
💥 An outstanding, multidisciplinary Scientific Programme featuring the latest technologies, treatments, and techniques in all areas of urology
💥An internationally diverse faculty of renowned experts
💥 An opportunity to network with industry leaders to form strategic partnerships
💥 Access to world class urologists showcasing their research and latest innovations
💥 A place to meet friends and colleagues from around the world
Join us in person or virtually and save, register before June 30, 2359 EDT (UTC-4) https://t.co/5utNNPKn6i
Present your innovative research on the world stage! Submit your abstract for #SIU2025Edinburgh by April 3, 2025, and be part of shaping the future of urology. https://t.co/SakB2YzIaV
XVII SIMPÓSIO APU 2024 📣
É já nos próximos dias 18 a 20 de Outubro de 2024 no Centro de Conferências Tróia Design Hotel 📍
👉 Consulte AQUI o cartaz e o programa🔹https://t.co/bwX0bZpmRc
#simposioAPU#APU#urologia#inteligenciaartificial#simposioapu
A Comissão Organizadora do Simpósio APU 2024 está a preparar a Corrida APU 2024!🏃
🗓 18 de outubro, sexta-feira
⏰ 18:30
📍 Largada no Centro de Conferências do Troia Design Hotel
A participação é gratuita, junte-se a nós! 🌟
#APU#urologia#simposioapu#corridaapu2024
Interpreting and Reporting Odds Ratios (OR) and Hazard Ratios (HR)
1/ Introduction:
Odds Ratios (OR) and Hazard Ratios (HR) are common metrics in epidemiological and clinical studies. They help us quantify associations between exposures and outcomes. Understanding and correctly interpreting these metrics is essential for drawing meaningful conclusions.
2/ Odds Ratio (OR):
The OR represents the odds of an event occurring in one group versus the odds of it occurring in another. It's often used in case-control studies.
OR = (odds of event in exposed group) / (odds of event in non-exposed group)
3/ OR Interpretation:
• OR = 1: No difference in odds between groups
• OR > 1: Greater odds of the event in the exposed group
• OR < 1: Lower odds of the event in the exposed group
4/ Hazard Ratio (HR):
HR is a measure of how often a particular event happens in one group compared to another, over time. It’s commonly used in survival analysis.
HR = (hazard rate in exposed group) / (hazard rate in non-exposed group)
5/ HR Interpretation:
• HR = 1: No difference in hazard between groups
• HR > 1: Higher hazard of the event in the exposed group
• HR < 1: Lower hazard of the event in the non-exposed group
6/ Key Considerations:
• Confidence Intervals (CI): Always report CIs along with ORs and HRs. A CI that includes 1 suggests that the result might not be statistically significant.
7/ Adjusted vs. Unadjusted:
• Adjusted ratios consider confounders, whereas unadjusted don't. Always clarify which type you're reporting, and consider potential confounders in your study.
8/ Causation vs. Association:
• OR and HR only measure association, NOT causation. Other evidence is needed to infer causality.
9/ Clinical vs. Statistical Significance:
• A statistically significant OR or HR might not be clinically meaningful. Consider the effect size, and the clinical context.
10/ External Validity:
• An OR or HR from one population may not apply to another. Always consider the study's population, and be cautious when generalizing results.
11/ Limitations:
• Like all statistical measures, ORs and HRs have limitations. Be transparent about potential biases, confounders, and other limitations in your study.
12/ Conclusion:
Interpreting and reporting ORs and HRs correctly is crucial for clear communication in research. Always consider the context, report confidence intervals, and remember the difference between association and causation.
(Note: This is a basic overview and there are more detailed nuances and considerations when interpreting ORs and HRs in different contexts.)
#Epidemiology #Statistics #DataScience
Webinar Conversas APU 📣 Com o tema: Disfunções Sexuais no Jovem Adulto
🔹Oradores: Ana Amaral, Artur Palmas, Maria José Freire
🔹Moderadores: Isaac Braga
Quinta-feira, dia 6 de julho, às 21 horas.
Link 👉 https://t.co/owge7mscyd
#conversasAPU#APU#urologia
Representação portuguesa no LXXXVI Congreso nacional de Urologia em Granada. Muchas Gracias @ResidentesAEU@InfoAeu @ESeguiMoya os vemos en Coimbra en el centenário @apurologia
¿Eres urólogo?
Reserva tu plaza en el #ResidentPlay y descubre junto a @ESeguiMoya @malvarezmaestro y @JGomezRivas la actualización del Libro del Residente de Urología durante el Congreso Nacional de la @InfoAeu.
¿Te lo vas a perder? Tus Co-Rs no lo harían.
A male patient has a detrusor pressure at maximum flow rate of 70 cm H2O, a maximum detrusor pressure of 80 cm H2O and a maximum flow rate of 8 mL/sec. What is his bladder outflow obstruction index? #Uroquiz
Lower mortality of #prostatecancer with increasing number and closeness of relatives in the family affected.
Read more 👇
https://t.co/4jbCOM8XUm
@marcobrooko @HolsUroLols @zx8754@roodvdb
👩🎓👨🎓 Registration for EUREP23, the European Urology Residents Education Programme, is now open. Join us for state-of-the-art lectures, discussions, videos and test-your-knowledge sessions. Don't miss out!
#EUREP23
https://t.co/zQjCpf3HyR
It is this time of the year again: TOP 10 GU Oncology clinical papers/trials in 2022:
Some negative, some positive, but we learned from all!
Feel free to add more & retweet & tag anyone involved
This is not an exhaustive list!
@OncoAlert@danafarber#OnwardFor2023
In case of PSA progression or change in DRE or MRI findings, do not progress to active treatment without a repeat biopsy.
#EAUGuidelines#ProstateCancer
https://t.co/hdC4C5ushK